NCT06431906View on ClinicalTrials.gov

Transdermal Fentanyl as a Form of Rebound Pain Reduction in Fast Track Programme in Primary Knee Arthroplasty.

Not yet recruitingOBSERVATIONAL

Enrollment

106

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

March 30, 2026

Study Completion Date

March 30, 2026

Conditions

Postoperative Pain

All Listed Sponsors

lead

Oscar Diaz-Cambronero

OTHER

NCT06431906 - Transdermal Fentanyl as a Form of Rebound Pain Reduction in Fast Track Programme in Primary Knee Arthroplasty. | Biotech Hunter | Biotech Hunter